These results deeply suggest that the ”repair strategy” conducted using selected CFTR correctors successfully applied to cystic fibrosis and LGMD2D/R3 could be feasible in LGMD2E/R4 too. The gene discussed is CFTR; the disease is cystic fibrosis.